| |
| |
|
| Insider
Information: |
Enright Patrick G |
| Relationship: |
10% Owner |
| City: |
Burlingame |
| State: |
CA |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
16 |
|
| Direct
Shares |
3,308,185 |
|
|
Indirect Shares
|
27,432,603 |
|
|
| Direct
Value |
$8,963,626 |
|
|
|
Indirect Value
|
$114,702,131 |
|
|
| Total
Shares |
30,740,788 |
|
|
| Total
Value |
$123,665,757 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
6
|
1
|
|
Stock
price went up :
|
5
|
1
|
| Stock
price went down : |
1
|
0
|
| |
|
|
|
Gain/Loss Ratio : |
5.0
|
1.0
|
| Percentage
Gain/Loss : |
 95.0%
|
101.2%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Molecular Templates, Inc. |
MTEM |
Director |
2006-04-20 |
496 |
2007-03-01 |
0 |
Premium* |
|
|
Sequenom Inc |
SQNM |
Director |
2006-12-07 |
771 |
2006-12-07 |
3,333,333 |
Premium* |
|
|
Corcept Therapeutics Inc |
CORT |
Director |
2017-03-16 |
272,281 |
2017-03-16 |
114,675 |
Premium* |
|
|
Jazz Pharmaceuticals Inc |
JAZZ |
Director |
2023-08-14 |
20,946 |
2022-08-08 |
2,000 |
Premium* |
|
|
Esperion Therapeutics, Inc. |
ESPR |
Director |
2013-07-01 |
0 |
2015-03-19 |
18,361 |
Premium* |
|
|
Collegium Pharmaceutical, Inc |
COLL |
10% Owner |
2015-05-12 |
0 |
2015-05-12 |
65,270 |
Premium* |
|
|
Aimmune Therapeutics, Inc. |
AIMT |
Director |
2020-10-13 |
0 |
2020-10-10 |
0 |
Premium* |
|
|
Aptinyx Inc. |
APTX |
Director |
2020-01-10 |
95,000 |
2020-01-10 |
3,356,746 |
Premium* |
|
|
Tricida, Inc. |
TCDA |
|
2018-07-02 |
0 |
2018-07-02 |
3,019,734 |
Premium* |
|
|
Venus Concept Inc |
VERO |
10% Owner |
|
0 |
2019-11-07 |
3,666,119 |
Premium* |
|
|
89bio, Inc. |
ETNB |
10% Owner |
2019-11-11 |
0 |
2020-11-16 |
891 |
Premium* |
|
|
Sierra Oncology Inc |
SRRA |
10% Owner |
2020-01-29 |
0 |
2022-01-25 |
1,964,771 |
Premium* |
|
|
Inozyme Pharma, Inc. |
INZY |
10% Owner |
2020-07-28 |
0 |
2022-04-19 |
4,174,379 |
Premium* |
|
|
Eargo, Inc. |
EAR |
10% Owner |
2021-04-14 |
2,918,691 |
2021-04-14 |
5,012 |
Premium* |
|
|
Vera Therapeutics, Inc. |
VERA |
Director, 10% Owner |
2021-05-18 |
0 |
2023-02-06 |
5,144,212 |
Premium* |
|
|
Lexeo Therapeutics, Inc. |
LXEO |
10% Owner |
2023-11-07 |
0 |
2023-11-07 |
2,567,100 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
169 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 1 of 7
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| TCDA |
Tricida, Inc. |
|
• • • |
2018-07-02 |
4 |
A |
$0.00 |
$0 |
I/I |
2,888,155 |
2,888,155 |
0 |
- |
|
| TCDA |
Tricida, Inc. |
|
• • • |
2018-07-02 |
4 |
B |
$19.00 |
$2,500,001 |
I/I |
131,579 |
3,019,734 |
0.01 |
- |
|
| COLL |
Collegium Pharmaceutical,... |
10% Owner |
– – • |
2015-05-12 |
4 |
A |
$0.00 |
$0 |
I/I |
3,121,842 |
61,340 |
0 |
- |
|
| COLL |
Collegium Pharmaceutical,... |
10% Owner |
– – • |
2015-05-12 |
4 |
B |
$12.00 |
$2,400,000 |
I/I |
200,000 |
65,270 |
1.5 |
- |
|
| VERO |
Venus Concept Inc |
10% Owner |
– – • |
2019-11-07 |
3 |
IO |
$0.00 |
$0 |
I/I |
0 |
3,666,119 |
|
- |
|
| ETNB |
89bio, Inc. |
10% Owner |
– – • |
2019-11-11 |
4 |
B |
$16.00 |
$9,200,000 |
I/I |
575,000 |
575,000 |
1.5 |
- |
|
| ETNB |
89bio, Inc. |
10% Owner |
– – • |
2019-11-13 |
4 |
A |
$0.00 |
$0 |
I/I |
1,916,787 |
2,491,787 |
0 |
- |
|
| SRRA |
Sierra Oncology Inc |
10% Owner |
– – • |
2020-01-29 |
4 |
A |
$0.00 |
$0 |
I/I |
1,477,320 |
1,477,320 |
0 |
- |
|
| ETNB |
89bio, Inc. |
10% Owner |
– – • |
2020-07-10 |
4 |
B |
$27.50 |
$2,999,975 |
I/I |
109,090 |
2,600,877 |
1.5 |
% |
|
| INZY |
Inozyme Pharma, Inc. |
10% Owner |
– – • |
2020-07-28 |
4 |
A |
$0.00 |
$0 |
I/I |
2,194,379 |
2,194,379 |
0 |
- |
|
| INZY |
Inozyme Pharma, Inc. |
10% Owner |
– – • |
2020-07-28 |
4 |
B |
$16.00 |
$10,000,000 |
I/I |
625,000 |
2,819,379 |
1.5 |
- |
|
| ETNB |
89bio, Inc. |
10% Owner |
– – • |
2020-11-16 |
4 |
A |
$0.00 |
$0 |
I/I |
5,944 |
891 |
0 |
- |
|
| ETNB |
89bio, Inc. |
10% Owner |
– – • |
2020-11-16 |
4 |
D |
$0.00 |
$0 |
I/I |
(850,000) |
1,750,877 |
0 |
- |
|
| EAR |
Eargo, Inc. |
10% Owner |
– – • |
2021-04-14 |
4 |
AS |
$0.00 |
$0 |
D/D |
(1,000,000) |
2,918,691 |
0 |
- |
|
| EAR |
Eargo, Inc. |
10% Owner |
– – • |
2021-04-14 |
4 |
A |
$0.00 |
$0 |
I/I |
5,012 |
5,012 |
0 |
- |
|
| SRRA |
Sierra Oncology Inc |
10% Owner |
– – • |
2022-01-25 |
4 |
OE |
$13.20 |
$6,434,353 |
I/I |
487,451 |
1,964,771 |
0 |
- |
|
| INZY |
Inozyme Pharma, Inc. |
10% Owner |
– – • |
2022-04-19 |
4 |
B |
$3.69 |
$4,999,950 |
I/I |
1,355,000 |
4,174,379 |
1.5 |
- |
|
| LXEO |
Lexeo Therapeutics, Inc. |
10% Owner |
– – • |
2023-11-07 |
4 |
B |
$11.00 |
$4,999,995 |
I/I |
454,545 |
2,567,100 |
1.5 |
- |
|
| LXEO |
Lexeo Therapeutics, Inc. |
10% Owner |
– – • |
2023-11-07 |
4 |
A |
$0.00 |
$0 |
I/I |
2,112,555 |
2,112,555 |
0 |
- |
|
| MTEM |
Molecular Templates, Inc. |
Director |
– • – |
2006-03-03 |
4 |
A |
$0.00 |
$0 |
D/D |
248 |
248 |
|
- |
|
| MTEM |
Molecular Templates, Inc. |
Director |
– • – |
2006-04-20 |
4 |
A |
$0.00 |
$0 |
D/D |
248 |
496 |
|
- |
|
| SQNM |
Sequenom Inc |
Director |
– • – |
2006-12-07 |
4 |
A |
$0.00 |
$0 |
D/D |
771 |
771 |
0 |
- |
|
| CORT |
Corcept Therapeutics Inc |
Director |
– • • |
2008-03-25 |
3 |
IO |
$0.00 |
$0 |
I/I |
0 |
3,530,450 |
|
- |
|
| CORT |
Corcept Therapeutics Inc |
Director |
– • • |
2008-11-11 |
4 |
A |
$1.45 |
$506,666 |
I/I |
349,425 |
3,879,875 |
0 |
- |
|
| CORT |
Corcept Therapeutics Inc |
Director |
– • • |
2009-02-06 |
4 |
B |
$0.69 |
$3,189,643 |
I/I |
4,642,857 |
8,522,732 |
2.25 |
- |
|
169 Records found
|
|
Page 1 of 7 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
